| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.09B | 23.24B | 21.91B | 18.66B | 12.70B |
| Gross Profit | 5.78B | 6.33B | 6.50B | 3.46B | 929.09M |
| EBITDA | 8.48B | 8.37B | 9.39B | 6.61B | -884.09M |
| Net Income | 3.93B | 4.04B | 3.35B | 1.46B | -4.99B |
Balance Sheet | |||||
| Total Assets | 92.12B | 81.04B | 72.08B | 68.25B | 59.39B |
| Cash, Cash Equivalents and Short-Term Investments | 14.43B | 5.66B | 5.63B | 4.24B | 3.52B |
| Total Debt | 35.45B | 33.71B | 29.71B | 30.22B | 25.46B |
| Total Liabilities | 42.45B | 42.06B | 34.98B | 34.68B | 29.47B |
| Stockholders Equity | 46.43B | 35.87B | 35.16B | 31.57B | 28.59B |
Cash Flow | |||||
| Free Cash Flow | 1.12B | 749.93M | 3.02B | -238.76M | 468.51M |
| Operating Cash Flow | 6.61B | 8.63B | 8.66B | 4.21B | 3.39B |
| Investing Cash Flow | -4.32B | -8.76B | -4.60B | -5.19B | -2.64B |
| Financing Cash Flow | 6.17B | -102.21M | -2.73B | 1.52B | -2.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$84.78B | 7.76 | 48.55% | 9.80% | 11.50% | 17.54% | |
71 Outperform | HK$89.08B | 7.02 | 11.33% | 12.81% | -9.21% | -41.30% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | HK$244.79B | 6.39 | 13.13% | 12.48% | -6.12% | -35.50% | |
63 Neutral | HK$15.44B | 26.23 | 2.51% | 2.88% | -19.46% | -55.11% | |
60 Neutral | HK$121.10B | 10.71 | 9.13% | 4.76% | 2.50% | -2.32% | |
47 Neutral | HK$33.35B | 14.39 | 5.24% | 4.16% | -8.82% | 11.45% |